PharVision Advisers’s Carnival PLC CUK Stock Holding History

PharVision Advisers’s Portfolio CUK Stock Details CUK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,778	Closed	-$206K	–	239
2025 Q4	$206K	Buy	+6,778	New	+$175K	0.1%	537

Other funds holding CUK

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

KCM Capital Shawnee, Kansas $618M AUM

OCAI

O'Connor Alternative Investments New York $1.37B AUM

PharVision Advisers's CUK Position: Q1 2026 in Review

PharVision Advisers sold out of Carnival PLC (CUK) in Q1 2026, closing a stake of 6,778 shares — an estimated $206K sold.

PharVision Advisers first reported a position in CUK in Q4 2025 and held it in 1 quarter. The position peaked at $206K in Q4 2025. 133 funds tracked by Wall St. Rank hold CUK as of Q1 2026.

PharVision Advisers reported no remaining Carnival PLC position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 6,778 Carnival PLC shares in Q1 2026, an estimated $206K.
PharVision Advisers first reported a position in Carnival PLC in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Carnival PLC position peaked at $206K in Q4 2025.
133 funds tracked by Wall St. Rank held Carnival PLC as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.